263 related articles for article (PubMed ID: 11971184)
1. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells.
Horie R; Watanabe T; Ito K; Morisita Y; Watanabe M; Ishida T; Higashihara M; Kadin M; Watanabe T
Am J Pathol; 2002 May; 160(5):1647-54. PubMed ID: 12000717
[TBL] [Abstract][Full Text] [Related]
3. Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts.
Nonaka M; Horie R; Itoh K; Watanabe T; Yamamoto N; Yamaoka S
Oncogene; 2005 Jun; 24(24):3976-86. PubMed ID: 15782119
[TBL] [Abstract][Full Text] [Related]
4. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Martinez RL; Alkan S
Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
[TBL] [Abstract][Full Text] [Related]
5. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
[TBL] [Abstract][Full Text] [Related]
6. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
[TBL] [Abstract][Full Text] [Related]
7. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.
Watanabe M; Ogawa Y; Ito K; Higashihara M; Kadin ME; Abraham LJ; Watanabe T; Horie R
Am J Pathol; 2003 Aug; 163(2):633-41. PubMed ID: 12875982
[TBL] [Abstract][Full Text] [Related]
8. The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma.
Nakashima M; Ishii Y; Watanabe M; Togano T; Umezawa K; Higashihara M; Watanabe T; Horie R
Cancer Sci; 2010 Nov; 101(11):2490-6. PubMed ID: 20735433
[TBL] [Abstract][Full Text] [Related]
9. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
[TBL] [Abstract][Full Text] [Related]
10. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
[TBL] [Abstract][Full Text] [Related]
11. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma.
Uchihara JN; Matsuda T; Okudaira T; Ishikawa C; Masuda M; Horie R; Watanabe T; Ohta T; Takasu N; Mori N
Int J Cancer; 2006 Mar; 118(5):1098-107. PubMed ID: 16152613
[TBL] [Abstract][Full Text] [Related]
13. Dimeric procyanidin B2 inhibits constitutively active NF-kappaB in Hodgkin's lymphoma cells independently of the presence of IkappaB mutations.
Mackenzie GG; Adamo AM; Decker NP; Oteiza PI
Biochem Pharmacol; 2008 Apr; 75(7):1461-71. PubMed ID: 18275936
[TBL] [Abstract][Full Text] [Related]
14. CD30 ligation induces nuclear factor-kappa B activation in human T cell lines.
McDonald PP; Cassatella MA; Bald A; Maggi E; Romagnani S; Gruss HJ; Pizzolo G
Eur J Immunol; 1995 Oct; 25(10):2870-6. PubMed ID: 7589085
[TBL] [Abstract][Full Text] [Related]
15. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells.
Gruss HJ; Ulrich D; Braddy S; Armitage RJ; Dower SK
Eur J Immunol; 1995 Jul; 25(7):2083-9. PubMed ID: 7621881
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
17. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
Emmerich F; Theurich S; Hummel M; Haeffker A; Vry MS; Döhner K; Bommert K; Stein H; Dörken B
J Pathol; 2003 Nov; 201(3):413-20. PubMed ID: 14595753
[TBL] [Abstract][Full Text] [Related]
18. Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Huang Q; Qin JZ; Martinez RL; Schnitzer B; Ni H; Nickoloff BJ; Alkan S
Mod Pathol; 2001 Apr; 14(4):297-310. PubMed ID: 11301346
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-kappaB activation.
Higuchi M; Matsuda T; Mori N; Yamada Y; Horie R; Watanabe T; Takahashi M; Oie M; Fujii M
Retrovirology; 2005 May; 2():29. PubMed ID: 15876358
[TBL] [Abstract][Full Text] [Related]
20. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
Bargou RC; Emmerich F; Krappmann D; Bommert K; Mapara MY; Arnold W; Royer HD; Grinstein E; Greiner A; Scheidereit C; Dörken B
J Clin Invest; 1997 Dec; 100(12):2961-9. PubMed ID: 9399941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
